Literature DB >> 2974850

Mixed lymphocyte reactions do not predict severity of graft versus host disease (GVHD) in HLA-DR compatible, sibling bone marrow transplants.

S H Lim1, W N Patton, S Jobson, T A Gentle, M Baynham, I M Franklin, B J Broughton.   

Abstract

Mixed lymphocyte reactions (MLRs) were measured in 25 HLA-A, B and DR compatible sibling bone marrow transplants. Only four of 25 MLRs were positive and in these the low reactivity was of doubtful clinical importance. There was no correlation between MLR and the subsequent development or severity of graft versus host disease (GVHD). A survey of bone marrow transplant units in the United Kingdom showed that most centres perform HLA-DR typing as well as an assessment of the MLR. Factors other than histocompatibility are important in the pathogenesis of GVHD and the data from this study suggest that conventional MLRs can be omitted in HLA-A, B and DR compatible sibling bone marrow transplants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974850      PMCID: PMC1141721          DOI: 10.1136/jcp.41.11.1155

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Both HLA-DR and HLA-DQ determinants contribute to HLA-Dw typing.

Authors:  G Sterkers; D Zeliszewski; A C Freidel; L Gebuhrer; H Betuel; J P Levy
Journal:  Hum Immunol       Date:  1987-11       Impact factor: 2.850

2.  HLA-DP matching and graft-versus-host disease in allogeneic bone marrow transplantation.

Authors:  G Pawelec; G Ehninger; H Schmidt; P Wernet
Journal:  Transplantation       Date:  1986-11       Impact factor: 4.939

Review 3.  Transplantation of hematopoietic stem cells (HSC).

Authors:  J A Hansen; P G Beatty; C Anasetti; P J Martin; E Mickelson; E D Thomas
Journal:  Br Med Bull       Date:  1987-01       Impact factor: 4.291

Review 4.  Cellular typing and functional heterogeneity of MHC-encoded products.

Authors:  H Festenstein; B Ollier
Journal:  Br Med Bull       Date:  1987-01       Impact factor: 4.291

Review 5.  Prevention and treatment of acute graft-versus-host disease.

Authors:  S Neudorf; A Filipovich; N Ramsay; J Kersey
Journal:  Semin Hematol       Date:  1984-04       Impact factor: 3.851

6.  Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora.

Authors:  D W van Bekkum; J Roodenburg; P J Heidt; D van der Waaij
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

7.  Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

Authors:  H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas
Journal:  Transplantation       Date:  1974-10       Impact factor: 4.939

8.  Risk factors for acute graft-versus-host disease.

Authors:  R P Gale; M M Bortin; D W van Bekkum; J C Biggs; K A Dicke; E Gluckman; R A Good; R G Hoffmann; H E Kay; J H Kersey
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

9.  HLA-DR typing as a predictor of MLC compatibility.

Authors:  R M Radvany; N Vaisrub
Journal:  Transplantation       Date:  1984-10       Impact factor: 4.939

10.  A possible predictive test for graft-versus-host disease in bone marrow graft recipients: the mixed-epidermal cell-lymphocyte reaction.

Authors:  M Bagot; C Cordonnier; A F Tilkin; M Heslan; J P Vernant; L Dubertret; J P Levy
Journal:  Transplantation       Date:  1986-03       Impact factor: 4.939

  10 in total
  2 in total

1.  A glow of HLA typing in organ transplantation.

Authors:  Batool Mutar Mahdi
Journal:  Clin Transl Med       Date:  2013-02-23

2.  Humanized Mouse Model as a Novel Approach in the Assessment of Human Allogeneic Responses in Organ Transplantation.

Authors:  Ashwin Ajith; Laura L Mulloy; Md Abu Musa; Valia Bravo-Egana; Daniel David Horuzsko; Imran Gani; Anatolij Horuzsko
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.